Company Profile

Apollo Endosurgery, Inc. is a medical technology company, which is focused on the development of medical devices to advance gastrointestinal therapeutic endoscopy. The Company develops and distributes devices that are used by surgeons and gastroenterologists for various procedures related to gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. The Company's products include the OverStitch Endoscopic Suturing System, which enables advanced endoscopic procedures from within the Gastrointestinal tract, or endolumenally, by allowing physicians to suture, especially full-thickness, and secure the approximation of tissue. The X-Tack Endoscopic HeliX Tacking System is a suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. The Orbera Intragastric Balloon System is a non-surgical alternative for interventional weight loss.

Employees

281

Sector

Medical Equipment, Supplies & Distribution

More about the company

23-04-06	Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P TMI Index	CI
23-04-06	Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from S&P Global BMI Index	CI
23-04-04	Apollo Endosurgery, Inc.(NasdaqGM:APEN) dropped from NASDAQ Composite Index	CI
23-04-03	Boston Scientific Corporation completed the acquisition of Apollo Endosurgery, Inc. from a group of shareholders.	CI
23-01-23	Cowen Downgrades Apollo Endosurgery to Market Perform From Outperform, Adjusts Price Target to $10 From $13	MT
23-01-04	Stifel Downgrades Apollo Endosurgery to Hold From Buy, Price Target is $10	MT
22-11-30	Lake Street Downgrades Apollo Endosurgery to Hold From Buy, Adjusts Price Target to $10 From $14	MT
22-11-29	Sector Update: Health Care Stocks Unable to Complete Tuesday Recovery	MT
22-11-29	Top Midday Gainers	MT
22-11-29	Apollo Endosurgery Shares Hit 52-Week High on Boston Scientific Deal	DJ
22-11-29	Boston Scientific Strikes $615 Million Deal to Buy Medical Tech Firm Apollo Endosurgery	MT
22-11-29	Easing Concerns Over China COVID-19 Protests Prompt Quiet Premarket Session for US Equities	MT
22-11-29	Top Premarket Gainers	MT

23-01-23	Cowen Downgrades Apollo Endosurgery to Market Perform From Outperform, Adjusts Price Target to $10 From $13	MT
23-01-04	Stifel Downgrades Apollo Endosurgery to Hold From Buy, Price Target is $10	MT
22-11-30	Lake Street Downgrades Apollo Endosurgery to Hold From Buy, Adjusts Price Target to $10 From $14	MT
22-05-04	Stephens Adjusts Apollo Endosurgery's Price Target to $9 from $8, Keeps Overweight Rating	MT
22-02-23	Stifel Nicolaus Adjusts Apollo Endosurgery Price Target to $10 From $12, Maintains Buy Rating	MT

23-04-04	APOLLO ENDOSURGERY, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, (form 8-K)	AQ
23-03-30	APOLLO ENDOSURGERY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
23-02-10	Apollo Endosurgery : Submission of Matters to a Vote of Security Holders - Form 8-K	PU
23-02-10	APOLLO ENDOSURGERY, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
22-12-29	APOLLO ENDOSURGERY, INC. : Unregistered Sale of Equity Securities (form 8-K)	AQ

Manager	Title	Age	Since
Christopher J. Gostout CTO	Chief Tech/Sci/R&D Officer	75	2016-12-31
Thomas Neudeck CTO	Chief Tech/Sci/R&D Officer	-	-
Tiffanie Gilbreth CTO	Chief Tech/Sci/R&D Officer	-	-

Director	Title	Age	Since
Vance Brown BRD	Director/Board Member	57	2023-04-03
Jonathan Monson BRD	Director/Board Member	52	2023-04-03

Apollo Endosurgery, Inc. Stock

Stocks

APEN

US03767D1081

Medical Equipment, Supplies & Distribution

Latest news: Apollo Endosurgery, Inc.

Analysts' recommendations: Apollo Endosurgery, Inc.

Press Releases: Apollo Endosurgery, Inc.

News in other languages: Apollo Endosurgery, Inc.

Quotes and Performance

Managers and Directors: Apollo Endosurgery, Inc.

Latest insider transactions

Medical Equipment

Company Profile

Date	Insider	Type	Main position	Quantity	% Market Cap.
4/4/23	CPMG, Inc.	Issuer sale	Company	6,222,270	13.0860%
4/4/23	Julie Shimer	Issuer sale	Director	113,319	0.2383%
4/4/23	Sharon O'Keefe	Issuer sale	Director	35,604	0.0749%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
APOLLO ENDOSURGERY, INC.	+0.81%	+0.91%	-	-	580M
ABBOTT LABORATORIES	+0.20%	+5.31%	-18.40%	+9.76%	181B
MEDTRONIC PLC	-0.73%	+7.09%	-1.08%	+30.33%	116B
STRYKER CORPORATION	+0.49%	+6.25%	-21.30%	+9.06%	113B
ESSILORLUXOTTICA	+3.83%	+5.50%	-50.59%	-5.64%	79.83B
CENCORA, INC.	-0.14%	+5.27%	+5.00%	+79.86%	65.06B
HOYA CORPORATION	+2.79%	+2.37%	+15.85%	+65.97%	54.35B
BECTON, DICKINSON AND COMPANY	-1.04%	+4.35%	+1.40%	-26.08%	52.23B
IDEXX LABORATORIES, INC.	+2.41%	+8.18%	-11.81%	+31.75%	44.15B
DEXCOM, INC.	-1.90%	+2.29%	+29.19%	+2.28%	32.47B
Average	+0.67%	+5.29%	-5.75%	+21.92%	82.07B
Weighted average by Cap.	+0.60%	+5.59%	-11.14%	+19.98%